Women's Health News: Breaking Women's Health News, Comments and Articles. - Page: 2

11:47 EDT 23rd October 2014 | BioPortfolio

Women's Health News - Page: 2Twitter RSS

Read the latest Women's Health News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Women's Health.

Search or Follow Our Women's Health - Page: 2 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Women's Health - Page: 2 News.
You can also follow our Women's Health - Page: 2 news stories on Twitter: @womens_womens

Showing "women breast cancer menopause Pregnancy" News Articles 26 to 50 of 24,000+

Thursday 23rd October 2014

Celgene Reports Third Quarter 2014 Operating and Financial Results

- 2014 Total Revenue and Adjusted Diluted EPS Guidance Raised - Phase II Data on GED-0301 Presented at United European Gastroenterology Week - Over 170 Abstracts Highlighting Celgene Products and Research at Major Medical Meetings Expected by Year-End Celgene Corporation (NASDAQ:CELG) reported net product sales of $1,957 ...

Extent of Surgery for Papillary Thyroid Cancer and Survival

Is there a survival advantage for total thyroidectomy over lobectomy in patients with papillary thyroid cancer? Annals of Surgery

MedLumics Introduces NITID Skin Imaging System at EADV

New imaging system allows for evaluation and monitoring of skin cancer without an invasive tissue biopsy MedLumics, a medical imaging company specializing in advanced optical coherence tomography (OCT) technology, debuted its

Upsher-Smith Presents New Data On The Administration Of Qudexy™ XR (Topiramate) Extended-Release Capsules Through Enteral Feeding Tubes

MAPLE GROVE, Minn., Oct. 23, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced the presentation of results from an in vitro study in which Qudexy™ XR (topiramate) extended-release capsules were opened and the capsule contents (extended-release beads) were passed through enteral feeding tubes of various sizes, utilizing different diluents.  The dat...

Imaging in 2020 Conference Focuses on Imaging the Immune System to Improve the Diagnosis and Treatment of Cancer, Heart Disease and Brain Disorders

CULVER CITY, Calif., Oct. 23, 2014 /PRNewswire-USNewswire/ -- The role of the immune system in the pathologies of cancer, heart diseases, and brain disorders was the focus of the Imaging in 2020: 2014 Conference, designed to discover new methods of using molecular imaging to image the immune system to better understand mechanisms of the diseases and improve therapy.  The Imaging in 2020:...

New drug to target skin cancer

Final guidance has been issued recommending another drug in the battle against a serious type of skin cancer.

New drug that targets melanoma approved by NICE

Final guidance has been issued recommending another drug in the battle against a serious type of skin cancer.

UK government and partners pay £230m for disease research

A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a range of new technologies aimed at identifying the causes of diseases such as cancer and dementia. The announcement was made today by the chancellor of the exchequer George Osborne, and aims to ‘dramatically speed-up’ diagnosis and treatment of these diseases. This will include ‘st...

SPDT Approved for use in Indiana Cancer Treatment Center

CARMEL, Ind., Oct. 23, 2014 /PRNewswire/ -- Sylvia Rosenberg was 27 when she found a lump in her right breast.  A biopsy confirmed she had early stage breast cancer.  Her doctor recommended a lumpectomy followed by chemotherapy and hormone therapy.  Sylvia had watched her aunt battle breast cancer, and she was determined to find a better treatment.  Her research confi...

The Hope Murals Project National Art Movement Culminates in Painting Event at Grand Central Terminal on October 23

NEW YORK, Oct. 23, 2014 /PRNewswire/ -- Chester, N.Y., resident Ellen Mayer wears many hats: professional artist, inventor, wife, mother, grandmother, recent college graduate and, as of October 23, muralist. Mayer is also a cancer survivor and kickboxer who notes, "My true grit helped me stay strong and knock out my cancer."  On October 23, the resolve Mayer has shown throughout her ca...

Eating Disorders: It Does Include You

The Bella Vita Launches New Eating Disorder Educational Advocacy Initiative Los Angeles, CA (PRWEB) October 23, 2014 Research has shown that eating disorders (including anorexia, bulimia, binge eating disorder and clinically significant eating disorders) impact 20 million women and 10 million men in the United States. Those are just the numbers for those who are diagnosed, as the National Associ...

CHEST Foundation Launches Campaign to Encourage People With COPD to Live Well

GLENVIEW, Ill., Oct. 23, 2014 /PRNewswire/ -- Take Control. Live Well. is the message behind a new chronic obstructive pulmonary disease (COPD) campaign launched today by the CHEST Foundation of the American College of Chest Physicians (CHEST). As part of National COPD Awareness Month in November, the campaign aims to encourage people with COPD to live well by adopting healthy lifestyles, wor...

Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference

WORCESTER, Mass. and TORONTO, Oct. 23, 2014 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc. (www.antigenexpress.com), will be participating in the 2014 BIO-Europe® Annual International Partnering Conference being held November 3-5 in Frankfurt, Germany. BIO-Europe® is...

Data Presented at the International Society of Paediatric Oncology (SIOP) Congress Show Palonosetron is a Valuable Option for Treating Pediatric Patients Receiving Moderately to Highly Emetogenic Chemotherapy

LUGANO, Switzerland, October 23, 2014 /PRNewswire/ -- ~ At a dose of 20 μg/kg, Palonosetron, administered as a single dose, is as effective as ondansetron 0.15 mg/kg given three times a day to a maximum dose of 32mg ~ No safety concerns were raised by the study Helsinn Group, the company focused on building quality cancer care, presented data at the I...

Interview: The Problem with Cancer Vaccines

You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeawy message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught up with Michael Hanna, the founder of Vaccinogen and creator of autologous patient-specific tuumor cell vaccine OncoVAX, to discuss why ther have been so many highprofile cancer vaccine failures and [&...

The Problem with Cancer Vaccines

You can’t treat a heterogeneous disease with a homogeneous treatment. That was the takeawy message from Vaccinogen’s founder at the World Vaccines Congress Europe Vaccine Nation caught up with Michael Hanna, the founder of Vaccinogen and creator of autologous patient-specific tuumor cell vaccine OncoVAX, to discuss why ther have been so many highprofile cancer vaccine failures and [&...

Scientists to use tiny particles to fight big diseases

Physicians will tell you: They are not winning the war on ovarian cancer. But FIU researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering to create a smarter, more...

Experts at Cancer Innovation Forum Call for Improving Cancer Research Ecosystem

WASHINGTON, Oct. 23, 2014 /PRNewswire-USNewswire/ -- At a time when cancer drug development is at a critical juncture, accelerating the delivery of promising new treatments will depend on one critical requirement: ensuring that patients, individually and collectively, are actively involved in the cancer research and drug development process from beginning to end. This was the consensus of leadin...

Grand Opening Held for New Medical Arts Building in Old Bridge

Raritan Bay Medical Center (RBMC), with locations in Old Bridge and Perth Amboy, NJ, is expanding services with a newly constructed Medical Arts Building at its Old Bridge location, providing the community easy access to a full continuum of care. Old Bridge, NJ (PRWEB) October 23, 2014 Raritan Bay Medical Center (RBMC) is expanding services with a newly constructed Medical Arts Building at its Ol...

Rapid modelling of cooperating genetic events in cancer through somatic genome editing

Cancer is a multistep process that involves mutations and other alterations in oncogenes and tumour suppressor genes. Genome sequencing studies have identified a large collection of genetic alterations that occur in human cancers. However, the determ...

In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system

Chromosomal rearrangements have a central role in the pathogenesis of human cancers and often result in the expression of therapeutically actionable gene fusions. A recently discovered example is a fusion between the genes echinoderm microtubule-asso...

Cancer: Metastasis risk after anti-macrophage therapy

Blocking the activity of macrophages may delay the spread of cancer. But new findings show that these immune cells can rapidly rebound to tumours after therapy withdrawal, accelerating lethal metastasis in mice.

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

Secretion of C–C chemokine ligand 2 (CCL2) by mammary tumours recruits CCR2-expressing inflammatory monocytes to primary tumours and metastatic sites, and CCL2 neutralization in mice inhibits metastasis by retaining monocytes in the bone marrow. He...

Get ready for the UK's fastest selling anti-aging serums!

NEW YORK, Oct. 23, 2014 /PRNewswire/ -- Seven years ago, Boots serums ignited a cult following – the original No7 Protect & Perfect and Protect & Perfect Intense Serums. Boasting clinically-proven anti-aging powers, these serums became the brand's gold-standard of drugstore anti-aging treatments. Now, following groundbreaking research, meticulous reformulation and extensive scientifi...

Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent

DUBLIN, Oct. 23, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found United States Patent No. 7,704,984 (the '984 Patent) to be valid and infringed by Lupin Pharmaceuticals, Inc. and Amneal Pharmaceuticals' Abbreviated New Drug Applications (ANDAs) for generic versions of Actavi...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks